Alimera Sciences Inc is a pharmaceutical company focused on creating treatments for eye diseases. Its main product, ILUVIEN, is an implant designed to treat diabetic macular edema, a condition that can lead to severe vision loss in people with diabetes. The company markets its products mainly to healthcare providers like physician offices and hospitals, both in the United States and internationally. Founded in 2003 and based in Alpharetta, Georgia, Alimera Sciences also collaborates on projects to expand its treatment offerings for various eye conditions.